Valproic Acid for the Treatment of Children with Mental Retardation and Mood Symptomatology
Pediatrics 86:467-472, Kastner,T.,et al, 1990
Clinical Valproate Toxicity Induced by Acetylsalicylic Acid
Neurol 37:1392-1394, Goulden,K.J.,et al, 1987
Choosing Anticonvulsant Medications to Manage Status Epilepticus
NEJM 382:2569-2572, Wu, K., 2020
Randomized Trial of Three Anticonvulsant Medications for Status Epilepticus
NEJM 381:2103-2113,2171, Kapur, J.,et al, 2019
A 22-year-old Man Presenting with Headache and Right Leg Jerks
Neurol 91:891-895, Schupper, A.J.,et al, 2018
Clinicopathologic Conference, Copper Deficiency Myelopathy
NEJM 377:1977-1984, Case 35-2017, 2017
Risk Factors of Hyperammonemia in Patients with Epilepsy Under Valproic Acid Therapy
Medicine 93:e66, Tseng, Y.L.,et al, 2014
Prenatal Valproate Exposure and Risk of Autism Spectrum Disorders and Childhood Autism
JAMA 309:1696-1703, Christensen, J.,et al, 2013
Autism Spectrum Disorders Following In Utero Exposure to Antiepileptic Drugs
Neurol 71:1923-1924, Bromley,R.I.,et al, 2008
Randomized Study of Intravenous Valproate and Phenytoin in Status Epilepticus
Seizure 16:527-532, Agarwal,P.,et al, 2007
Intravenous Sodium Valproate Versus Diazepam Infusion for the Control of Refractory Status Epilepticus in Children: A Randomized Controlled Trial
J Child Neurol 22:1191-1197, Mehta,V.,et al, 2007
Sodium Valproate vs Phenytoin in Status Epilepticus: A Pilot Study
Neurol 67:340-342, Misra,U.K.,et al, 2006
Efficacy of rapid IV administration of valproic acid for status epilepticus
Neurol 64:353-355, Limdi, N.A., et al, 2005
Valproate-Induced Hyperammonemic Encephalopathy in the Presence of Topiramate
Neurol 54:230-232, Hamer,H.M.,et al, 2000
Intravenous Valproic Acid for Myoclonic Status Epilepticus
Neurol 54:1201, Sheth,R.D. & Gidal,B.E., 2000
Intravenous Valproate in Pediatric Epilepsy Patients with Refractory Status Epilepticus
Neurol 54:2188-2189, Uberall,M.A.,et al, 2000
Intravenous Valproate is Well Tolerated in Unstable Patients with Status Epilepticus
Neurol 55:722-724, Sinha,S. & Naritoku,D.K., 2000
Protein C Deficiency Related to Valproic Acid Therapy: A Possible Association with Childhood Stroke
J Pediatr 137:714-718, Gruppo,R.,et al, 2000
Treatment of Absence Status with Intravenous Valproate
Neurol 52:889-890, Alehan,F.K.,et al, 1999
Clumsiness, Confusion, Coma, and Valproate
Lancet 353:1408, Ellaway,C.J.,et al, 1999
Intractable Epilepsy
Lancet 353:1238, Shuper,A.,et al, 1999
Status Epilepticus
NEJM 338:970-976, Lowenstein,D.H.&Alldredge,B.K., 1998
Antiepileptics and Blood Dyscrasias: A Cohort Study
Pharmacotherapy 18:1277-1283, Blackburn,S.C.F.,et al, 1998
Antiepileptic Drugs
NEJM 334:168-175, Brodie,M.J.&Dichter,M.A., 1996
Rational Polypharmacy in the Treatment of Epilepsy
(Ed) , Neurol (suppl) 45:S1-S38., Wilder,B.J., 1995
Safety of Intravenous Valproate
Ann Neurol 38:670-674, Devinsky,O.,et al, 1995
Valproic Acid-Induced Hyperammonemic Encephalopathy:MR Appearance
AJNR 15:1779-1781, Baganz,M.D.&Dross,P.E., 1994
Early Childhood Hepatocerebral Degeneration Misdiagnosed as Valproate Hepatotoxicity
Ann Neurol 32:767-775, Bicknese,A.R.,et al, 1992
Typical Absence Seizures in Adults:Clinical, EEG, Video-EEG Findings & Diagnostic/Syndr Consider
JNNP 55:1002-1008, Panayiotopoulos,C.P.,et al, 1992
Established Anticonvulsants and Treatment of Refractory Epilepsy
Lancet 336:350-354, Brodie,M.J., 1990
Valproate Prevents the Recurrence of Absence Status
Neurol 39:1294-1297, Berkovic,S.F.,et al, 1989
Valproate-Ethosuximide Combination Therapy for Refractory Absence Seizures
Arch Neurol 40:797-802, Rowan,A.J.,et al, 1983
Valproic Acid
NEJM 302:661-666, Brown,T.R., 1980
Rectal Valproate Syrup & Status Epilepticus
Neurol 30:1113-1114, Thorpy,M.J., 1980
Interaction Between Clonazepam & Sodium Valproate
NEJM 300:678-679, Watson,W.A., 1979
Acute Intoxication with Sodium Valproate
Ann Neurol 6:552-553, Chadwick,D.W.,et al, 1979
Rectal Administration of Sodium Valproate in Status Epilepticus
Neurol 28:897-899, Vajda,F.J.E.,et al, 1978